Literature DB >> 26331112

Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging.

Yu Kataoka1, Rishi Puri1, Stephen J Nicholls1.   

Abstract

Increasing evidence points to a critical role of inflammation in the development and propagation of atherosclerotic cardiovascular disease. Pathological studies in human and animal models have elucidated specific inflammatory mediators contributing to the progression and rupture of atherosclerotic plaque in the artery wall. These observations not only outline the importance of inflammation in atheroma progression but also the potential of anti-inflammatory therapeutic approaches to prevent and stabilize atherosclerotic disease. Intravascular ultrasonography enables direct atheroma visualization in vivo. Additionally, refinements in ultrasound technology permitting radiofrequency backscatter analysis enhance plaque characterization associated with disease instability. These imaging modalities will continue to provide opportunities for evaluating novel inflammatory mechanisms and anti-inflammatory therapies.

Entities:  

Keywords:  Intravascular ultrasound (IVUS); atherosclerosis; imaging; inflammation; plaque progression; plaque vulnerability

Year:  2015        PMID: 26331112      PMCID: PMC4536481          DOI: 10.3978/j.issn.2223-3652.2015.05.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  37 in total

Review 1.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.

Authors:  Paul M Ridker; Nancy Cook
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

3.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

4.  Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.

Authors:  Rishi Puri; Peter Libby; Steven E Nissen; Kathy Wolski; Christie M Ballantyne; Phillip J Barter; M John Chapman; Raimund Erbel; Joel S Raichlen; Kiyoko Uno; Yu Kataoka; E Murat Tuzcu; Stephen J Nicholls
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-01-20       Impact factor: 6.875

5.  Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.

Authors:  Atsushi Iwata; Shin-Ichiro Miura; Tohru Tanaka; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Akira Kawamura; Keijiro Saku
Journal:  Coron Artery Dis       Date:  2012-08       Impact factor: 1.439

6.  Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment.

Authors:  Shigemasa Tani; Ken Nagao; Takeo Anazawa; Hirofumi Kawamata; Shingo Furuya; Hiroshi Takahashi; Kiyoshi Iida; Michiaki Matsumoto; Takehiko Washio; Narimichi Kumabe; Atsushi Hirayama
Journal:  Am J Cardiol       Date:  2009-06-24       Impact factor: 2.778

7.  Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study).

Authors:  Christopher R Kelly; Giora Weisz; Akiko Maehara; Gary S Mintz; Roxana Mehran; Alexandra J Lansky; Helen Parise; Bernard de Bruyne; Patrick W Serruys; Gregg W Stone
Journal:  Am J Cardiol       Date:  2014-05-16       Impact factor: 2.778

8.  Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.

Authors:  Yu Kataoka; Mingyuan Shao; Kathy Wolski; Kiyoko Uno; Rishi Puri; E Murat Tuzcu; Stanley L Hazen; Steven E Nissen; Stephen J Nicholls
Journal:  Atherosclerosis       Date:  2013-12-19       Impact factor: 5.162

9.  Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment.

Authors:  Shigemasa Tani; Ken Nagao; Takeo Anazawa; Hirofumi Kawamata; Kiyoshi Iida; Michiaki Matsumoto; Yuichi Sato; Atsushi Hirayama
Journal:  Atherosclerosis       Date:  2008-02-16       Impact factor: 5.162

10.  Effect of folic acid supplementation on levels of circulating Monocyte Chemoattractant Protein-1 and the presence of intravascular ultrasound derived virtual histology thin-cap fibroatheromas in patients with stable angina pectoris.

Authors:  Kjetil H Løland; Øyvind Bleie; Elin Strand; Per M Ueland; Jan E Nordrehaug; Hector M Garcia-Garcia; Patrick W Serruys; Ottar Nygård
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more
  9 in total

1.  Sulindac-derived retinoid X receptor-α modulator attenuates atherosclerotic plaque progression and destabilization in ApoE-/- mice.

Authors:  Linghong Shen; Zhe Sun; Peng Nie; Ruosen Yuan; Zhaohua Cai; Caizhe Wu; Liuhua Hu; Shuxuan Jin; Hu Zhou; Xiaokun Zhang; Ben He
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

2.  Intraluminal Carotid Artery Thrombus in COVID-19: Another Danger of Cytokine Storm?

Authors:  A Y Mohamud; B Griffith; M Rehman; D Miller; A Chebl; S C Patel; B Howell; M Kole; H Marin
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

3.  Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.

Authors:  Hema Kothari; Anh T Nguyen; Xiaohong Yang; Yohei Hisada; Sotirios Tsimikas; Nigel Mackman; Angela Taylor; Coleen A McNamara
Journal:  J Cardiovasc Transl Res       Date:  2018-01-17       Impact factor: 4.132

Review 4.  Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.

Authors:  Adam J Nelson; Maddalena Ardissino; Peter J Psaltis
Journal:  Ther Adv Chronic Dis       Date:  2019-11-01       Impact factor: 5.091

Review 5.  Rapid Progression of Coronary Atherosclerosis: A Review.

Authors:  Priyank Shah; Sharad Bajaj; Hartaj Virk; Mahesh Bikkina; Fayez Shamoon
Journal:  Thrombosis       Date:  2015-12-28

6.  Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation.

Authors:  Linghong Shen; Zhe Sun; Shichun Chu; Zhaohua Cai; Peng Nie; Caizhe Wu; Ruosen Yuan; Liuhua Hu; Ben He
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

7.  Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways.

Authors:  Jing Ni; Yuanmin Li; Weiming Li; Rong Guo
Journal:  Lipids Health Dis       Date:  2017-10-10       Impact factor: 3.876

Review 8.  Long-COVID diagnosis: From diagnostic to advanced AI-driven models.

Authors:  Riccardo Cau; Gavino Faa; Valentina Nardi; Antonella Balestrieri; Josep Puig; Jasjit S Suri; Roberto SanFilippo; Luca Saba
Journal:  Eur J Radiol       Date:  2022-01-19       Impact factor: 3.528

9.  C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV.

Authors:  Adam J Nelson; Rishi Puri; Danielle M Brennan; Todd J Anderson; Leslie Cho; Christie M Ballantyne; John Jp Kastelein; Wolfgang Koenig; Helina Kassahun; Ransi M Somaratne; Scott M Wasserman; Steven E Nissen; Stephen J Nicholls
Journal:  Am J Prev Cardiol       Date:  2020-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.